Stock Code: 002727 stock abbreviation: Yixintang Pharmaceutical Group Co.Ltd(002727) Announcement No.: 2021-157 Yixintang Pharmaceutical Group Co.Ltd(002727)
Announcement on the voting results of the fourth extraordinary general meeting of shareholders and small and medium-sized investors in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. There is no proposal to add, reject or change in this shareholders’ meeting.
2. This shareholders’ meeting does not involve changing the resolution of the previous shareholders’ meeting.
1、 Convening and attendance of the meeting
(i) Meetings held
1. Meeting time:
(1) On site meeting time: 14:00 p.m. on Tuesday, December 14, 2021.
(2) Online voting time: December 14, 2021. The specific time for online voting through the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on December 14, 2021; the specific time for online voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 a.m. to 15:00 p.m. on December 14, 2021 Time.
2. Venue: Yixintang Pharmaceutical Group Co.Ltd(002727) conference room
3. Convening method: on-site voting and online voting
4. Convener: the board of directors of the company
5. Moderator: Mr. Ruan Hongxian, chairman
6. The notice of the meeting was published in the securities times, China Securities Journal, securities daily and cninfo.com on November 27, 2021. The convening and convening procedures of this meeting comply with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the stock listing rules of Shenzhen Stock Exchange and the articles of association. The meeting is legal and effective.
（2） Attendance at meetings
There were 23 shareholders, shareholder representatives and authorized voting agents attending the meeting, with 307126624 representative shares, accounting for 51.5157% of the total share capital of 596180525 shares of the company. Of which:
1. 10 shareholders, shareholder representatives and entrusted voting agents participated in the on-site voting, with 296960181 representative shares, accounting for 49.8104% of the total share capital of 596180525 shares of the company;
2. 13 shareholders voted online, representing 10166443 shares, accounting for 1.7053% of the company’s total share capital of 596180525 shares;
3. A total of 15 small and medium-sized investors participated in the meeting through on-site and network, with 10224443 shares owned and represented, accounting for 1.7150% of the company’s total share capital of 596180525 shares;
4. The company’s directors, supervisors, senior managers, lawyer Li Da and lawyer Zheng Tingting of Beijing Jingtian Gongcheng law firm attended and attended the meeting as nonvoting delegates. The convening and convening procedures of this meeting comply with the relevant provisions of the company law, the rules for the general meeting of shareholders of listed companies and the articles of association.
2、 Deliberation and voting of proposals
The shareholders’ meeting considered and voted the following proposals by means of on-site open voting and online voting. The specific voting conditions are as follows:
1. Review the proposal on the application of the company and its subsidiaries for comprehensive credit line from relevant banks
Voting results:
307024207 shares were approved, accounting for 99.9667% of the total voting shares;
102417 opposed shares, accounting for 0.0333% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors: 10122026 shares were agreed, accounting for 98.9983% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 102417 opposed shares, accounting for 1.0017% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
2. Review the proposal on the company’s approval of subsidiaries to apply for comprehensive credit line from relevant banks and provide guarantee for them
Voting results:
307024207 shares were approved, accounting for 99.9667% of the total voting shares;
102417 opposed shares, accounting for 0.0333% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors: 10122026 shares were agreed, accounting for 98.9983% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 102417 opposed shares, accounting for 1.0017% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
3. Deliberating the proposal on re employment of accounting firm
Voting results:
307103824 shares were approved, accounting for 99.9926% of the total voting shares;
0 dissenting shares, accounting for 0% of the total voting shares;
22800 shares abstained, accounting for 0.0074% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 10201643 shares are agreed, accounting for 99.7770% of the total valid voting shares of small and medium-sized investors attending the meeting; 0 dissenting shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 22800 shares were abstained, accounting for 0.2230% of the total valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
4. Review the proposal on the company’s use of some temporarily idle funds raised by non-public development banks in 2017 to purchase financial products
Voting results:
307126124 shares were approved, accounting for 99.9998% of the total voting shares;
Against 500 shares, accounting for 0.0002% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 10223943 shares are agreed, accounting for 99.9951% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Against 500 shares, accounting for 0.0049% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
5. Review the proposal on the company’s use of some temporarily idle funds raised from the public issuance of convertible corporate bonds in 2018 to purchase financial products
Voting results:
307126124 shares were approved, accounting for 99.9998% of the total voting shares;
Against 500 shares, accounting for 0.0002% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 10223943 shares are agreed, accounting for 99.9951% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Against 500 shares, accounting for 0.0049% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
6. Review the proposal on the company’s use of some temporarily idle self owned funds to purchase financial products
Voting results:
303469340 shares were approved, accounting for 98.8092% of the total voting shares;
3657284 opposed shares, accounting for 1.1908% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 6567159 shares are agreed, accounting for 64.2300% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 3657284 opposed shares, accounting for 35.7700% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
7. Review the proposal on the prediction of daily related party transactions between the company and Hongyun Pharmaceutical Co., Ltd., enterprises under its control and Yunnan Tonghong hot spring Co., Ltd. in 2022
Voting result: Mr. Ruan Hongxian and Ms. Liu Qiong, affiliated shareholders, avoided voting.
47240934 shares were approved, accounting for 99.9989% of the total voting shares;
0 dissenting shares, accounting for 0% of the total voting shares;
500 shares abstained, accounting for 0.0011% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 10223943 shares are agreed, accounting for 99.9951% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 0 dissenting shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 500 shares, accounting for 0.0049% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
8. Review the proposal on the prediction of daily connected transactions between the company and Ms. Liu Qiong and the enterprises under their control in 2022
Voting result: Mr. Ruan Hongxian and Ms. Liu Qiong, affiliated shareholders, avoided voting.
47241434 shares agreed, accounting for 100% of the total voting shares;
0 dissenting shares, accounting for 0% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 10224443 shares are agreed, accounting for 100% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 0 dissenting shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
9. Review the proposal on the prediction of daily connected transactions between the company and Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) and its subsidiaries in 2022
Voting result: related shareholders Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) abstained from voting.
271159633 shares, accounting for 100% of the total voting shares;
0 dissenting shares, accounting for 0% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 10224443 shares are agreed, accounting for 100% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 0 dissenting shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
10. Deliberating the proposal on the prediction of daily related party transactions between the company and Yunnan Guohe Pharmaceutical Co., Ltd. in 2022, the voting result: Mr. Ruan Guowei, a related shareholder, avoided voting.
306876624 shares, accounting for 100% of the total voting shares;
0 dissenting shares, accounting for 0% of the total voting shares;
0 shares abstained, accounting for 0% of the total voting shares.
Among them, the voting of small and medium-sized investors is: 10224443 shares are agreed, accounting for 100% of the total number of valid voting shares of small and medium-sized investors attending the meeting; 0 dissenting shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares of small and medium-sized investors attending the meeting.
The voting result was adopted.
11. Review the proposal on the remuneration of directors (non independent directors) of the company in 2022
Voting result: related shareholders Mr. Ruan Hongxian, Ms. Liu Qiong, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) , Ms. Guo Chunli, Mr. Ruan Guowei and Mr. Zhang Yong avoided voting.
10524443 shares, accounting for 100% of the total voting shares;
0 dissenting shares, accounting for 0% of the total voting shares;
waiver
